Business Context and Reporting Period
This Form 8-K was filed by Anthem, Inc. (now Elevance Health, Inc.) on December 8, 2015. The report discloses a specific corporate governance event regarding the appointment of a senior executive officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of Ronald W. Penczek as Chief Accounting Officer, effective immediately on December 8, 2015. Concurrently, John E. Gallina, who served as Chief Accounting Officer since 2011, assumed the role of Chief Financial Officer of the Company's Commercial and Specialty Business Division.
Management Commentary and Risks
Management notes that Mr. Penczek has held numerous financial positions with the Company since 2005, most recently as Vice President and Controller since August 2013. The filing states there are no arrangements or understandings between Mr. Penczek and other persons regarding his selection, no family relationships with directors or officers, and no direct or indirect material interest in transactions requiring disclosure under Item 404(a) of Regulation S-K. No specific risks, contingencies, or unusual items are disclosed in this report.
Investor Verification Checklist
- Verify the effective date of Ronald W. Penczek's appointment as Chief Accounting Officer.
- Confirm the new role assigned to John E. Gallina within the Commercial and Specialty Business Division.
- Review the Company's Executive Agreement Plan to understand the covenants applicable to Mr. Penczek.
- Check for any subsequent filings regarding the transition of duties between the two officers.